Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in a Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease

Gouard, S; Maurel, C; Marionneau-Lambot, S; Dansette, D; Bailly, C; Guerard, F; Chouin, N; Haddad, F; Alliot, C; Gaschet, J; Eychenne, R; Kraeber-Bodere, F; Cherel, M

Cherel, M (corresponding author), Univ Nantes, INSERM, CNRS, CRCINA, F-44000 Nantes, France.; Cherel, M (corresponding author), Grp Interet Publ Arronax, F-44800 St Herblain, France.; Cherel, M (corresponding author), ICO Rene Gauducheau Canc Ctr, F-44800 St Herblain, France.

CANCERS, 2020; 12 (9):

Abstract

Simple Summary Multiple myeloma is a cancer that remains incurable. Among the many therapies under evaluation, antibodies can be used as vehicles to t......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索